Primary Record
Peramivir
- In stock
- 9,069 g
- Purity
- 98.6 %
- CAS
- 330600-85-6
Compound Identifiers & Properties
- CAS
- 330600-85-6
- PubChem CID
- 154234
- SMILES
- CCC(CC)[C@@H]([C@H]1[C@@H](C[C@@H]([C@H]1O)C(=O)O)N=C(N)N)NC(=O)C
- Canonical SMILES
- CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1N=C(N)N
Names & Synonyms
- Peramivir
- Rapiacta
- 330600-85-6
- Peramivir anhydrous
- null
- RAPIVAB
- PeramiFlu
- BCX-1812
- Peramivir hydrate
- Peramivir trihydrate
- (+/-)-Peramivir
- Peramivir [USAN]
- RWJ-270201
- PERAMIVIRUM
- Peramivir [USAN:INN]
- Peramivir, (+/-)-
- 9ZS94HQO3B
- Peramivir,(+/-)-
- PERAMIVIR [INN]
- UNII-9ZS94HQO3B
- PERAMIVIR [MI]
- 229614-55-5
- Peramivir Impurity 123
- AC1L4BWX
- BCX 1812
- BCX1812
- RefChem:860138
- CHEBI:85202
- D0Z3SV
- UNII-QW7Y7ZR15U
- UNII-IDL9Q29886
- QW7Y7ZR15U
- RWJ270201
- cc-227
- orb134426
- RWJ 270201
- SCHEMBL744373
- DTXSID10904727
- MFCD09837902
- BDBM5024
- C15H28N4O4
- CHEMBL139367
- IDL9Q29886
- orb1705122
- SCHEMBL12795462
- J05AH03
- RWJ-270201-162 ANHYDROUS
- BCPP000117
- DTXCID801333836
- GLXC-05004
- 330600-85-6 (free)
- ZINC3981610
- ABP000969
- BDBM50181441
- CID154234
- CP0131
- EBC-26603
- HY-17015A
- AKOS016007760
- AKOS037652424
- C15-H28-N4-O4
- PERAMIVIR (+/-)-FORM [MI]
- (1S,2S,3R,4R)-3-((S)-1-Acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylic acid
- ACN-028788
- CS-0638
- DB06614
- DT-0029
- FP65126
- RL02720
- RL03191
- NCGC00346433-06
- NCGC00346433-07
- 229614-56-6
- AC-22715
- AJ-47581
- C15-H28-N4-O4.3H2-O
- RWJ-270201;BCX-1812
- (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid
- AB2000310
- ST2402123
- A3709
- FT-0660251
- FT-0696501
- NS00069710
- P2892
- (1S,2S,3R,4R)-4-carbamimidamido-3-[(1S)-1-acetamido-2-ethylbutyl]-2-hydroxycyclopentane-1-carboxylic acid
- J2.838.412B
- A11124
- W19713
- AB01566838_01
- EN300-7412041
- 600P856
- A851943
- A912714
- Q412734
- (1S,2R,3R,4R)-3-(1-acetamido-2-ethyl-butyl)-4-(diaminomethylideneamino)-2-hydroxy-cyclopentane-1-carboxylic acid
- A1006259
- S-021812
- BRD-K00519864-341-02-5
- BRD-K00519864-341-03-3
- 3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid
- 3-(1-ACETYLAMINO-2-ETHYL-BUTYL)-4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID
- 1041434-82-5
- BCZ
- (1s,2s,3r,4r)-3-((1s)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino)-2-hydroxycyclopentane
- (1S,2S,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid
- (1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic Acid
- (1S,2S,3S,4R)-4-[(DIAMINOMETHYLIDENE)AMINO]-3-[(1S)-1-ACETAMIDO-2-ETHYLBUTYL]-2-HYDROXYCYCLOPENTANE-1-CARBOXYLIC ACID
- 3(R)-[1(S)-Acetamido-2-ethylbutyl]-4(R)-guanidino-2(S)-hydroxycyclopentane-1(S)-carboxylic acid
- Cyclopentanecarboxylic acid, 3-((1R)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1R,2R,3S,4S)-rel-
- Cyclopentanecarboxylic acid, 3-((1S)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1S,2S,3R,4R)-
- Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-
- (-)-(1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-{[amino(imino)methyl]amino}-2-hydroxycyclopentanecarboxylic Acid
- (1S,2S,3R,4R)-3-((1S)-1-acetamido-2-ethylbutyl)-4-((amino(imino)methyl)amino)-2-hydroxycyclopentanecarboxylic acid trihydrate
- (1S,2S,3R,4R)-3-((1S)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino-2-hydroxycyclopentanecarboxylic acid, trihydrate
- (1S,2S,3R,4R)-3-((1S)-1-ACETYLAMINO-2-ETHYLBUTYL)-4-((AMINOIMINOMETHYL)AMINO)-2-HYDROXYCYCLOPENTANECARBOXYLIC ACID
- (1S,2S,3R,4R)-3-(1-acetaMido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylic acid
- (1S,2S,3R,4R)-3-(1-acetaMido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylic acid (Peramivir)
- (1S,2S,3R,4R)-3-[(1S)-1-(ACETYLAMINO)-2-ETHYLBUTYL]-4-{[AMINO(IMINO)METHYL]AMINO}-2-HYDROXYCYCLOPENTANE-1-CARBOXYLIC ACID
- (1S,2S,3R,4R)-3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-carbamimidamido-2-hydroxycyclopentanecarboxylic acid
- (1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-guanidino-2-hydroxycyclopentanecarboxylic acid
- (1S,2S,3R,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentanecarboxylic acid
- (1S,2S,3R,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-carbamimidamido-2-hydroxycyclopentane-1-carboxylic acid
- (1S,2S,3S,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-((diaminomethylene)amino)-2-hydroxycyclopentane-1-carboxylic acid
- (1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentanecarboxylic acid
- (1S,2S,3S,4R)-3-[(1S)-1-Acetamido-2-ethylbutyl]-4-[(diaminomethylidene)amino]-2-hydroxycyclopentane-1-carboxylic acid
- (3ar,4r,6s,6as)-methyl 4-(tert-butoxycarbonylamino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3ah-cyclopenta[d]isoxazole-6-carboxylate
- 1988779-13-0
- 1N-(1-(5-diaminomethylamino-3-dihydroxymethyl-2-hydroxy-(3S,5R)-cyclopentyl)-2-ethylbutyl)acetamide (BCX-1812)
- CYCLOPENTANECARBOXYLIC ACID, 3-((1S)-1-(ACETYLAMINO)-2-ETHYLBUTYL)-4-((AMINOIMINOMETHYL)AMINO)-2-HYDROXY-, (1R,2R,3S,4S)-REL-
- Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-; (1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic acid; (1S,2S,3R,4R)-3-((1S)-1-Acetamido-2-ethylbutyl)-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid; (1S,2S,3S,4R)-3-((1S)-1-Acetamido-2-ethylbutyl)-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid; BCX 1812; Peramivir; RWJ 270201; Rapiacta; Rapivab
- Cyclopentanecarboxylicacid,3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-,(1R,2R,3S,4S)-rel-